Amatuximab Completed Phase 1 Trials for Non-Small Cell Lung Carcinoma (NSCLC) / Malignant Neoplasm of Pancreas / Mesothelioma / Ovarian Cancer Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers